Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback